Elizabeth K. O'Donnell, MD^1,2, Jacob P. Laubach, MD^2,3, Andrew J. Yee, MD^1,2,4, Carol A. Huff, MD⁵, Frank G. Basile, MD⁶, Philip M. Wade Jr., MD⁶, Claudia E. Paba-Prada, MD^2,3, Irene M. Ghobrial, MD^2,3, Robert L. Schlossman, MD^2,3, Nicole R. Couture, BSN, RN^1*, Lauren Doherty^1*, Hannah Lyons^4*, Caroline English^5*, Nikhil C. Munshi, MD^2,3, Kenneth C. Anderson, MD^2,3, Paul G. Richardson, MD^2,3 and Noopur S. Raje, MD^1,2

¹Massachusetts General Hospital Cancer Center, Boston, MA
²Harvard Medical School, Boston, MA
³Dana-Farber Cancer Institute, Boston, MA
⁴Massachusetts General/North Shore Cancer Center, Danvers, MA
⁵Johns Hopkins University, Baltimore, MD
⁶Cape Cod Healthcare, Hyannis, MA

Jacalyn Rosenblatt, MD^1,2, Irit Avivi, MD^3*, Noam Binyamini, MD^3*, Lynne Uhl, MD¹, Poorvi Somaiya^1*, Dina Stroopinsky, PhD^1*, Kristen Anna Palmer^1*, Maxwell Douglas Coll^1*, Tami Katz, PhD^3*, Lina Bisharat, MSc^3*, Robin Joyce, MD², James D. Levine, MD¹, Jon E. Arnason, MD¹, Katarina Luptakova, MD¹, Malgorzata McMasters, MD^1*, Salvia Jain, MD^1,4, Merav Leiba, MD^5*, Aya Sato-Dilorenzo, RN, BSN, OCN^1*, Emma Logan^1*, Mary Paty Bryant^1*, Viki Held^3*, Paul G. Richardson, MD⁶, Jacob P. Laubach, MD⁶, Arnon Nagler, MD, MSc⁵, Kenneth C. Anderson, MD⁷, Nikhil C. Munshi, MD⁶, Jacob M. Rowe, MD³, Donald Kufe, MD^6* and David E. Avigan, MD¹

¹Beth Israel Deaconess Medical Center, Boston, MA
²Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
³Rambam Health Care Campus, Haifa, Israel
⁴Malignant Hematology and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
⁵Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
⁶Dana-Farber Cancer Institute, Boston, MA
⁷Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Shaji K. Kumar, MD¹, Ravi Vij, MD, MBA², Jonathan L. Kaufman, MD³, Joseph R. Mikhael, MD⁴, Thierry Facon, MD⁵, Brigitte Pegourie, MD^6*, Lotfi Benboubker, M, D PhD^7*, Philippe Moreau, MD^8*, Martine Amiot, PhD^8*, Stefanie Alzate, MS^9*, Lura Morris, BA^9*, Jeremy Ross, PhD^9*, Martin Dunbar, DrPH^9*, Ming Zhu, PhD^9*, Paulo Maciag, MD^9*, Suresh Agarwal, PhD^9*, Joel Leverson, PhD^9*, Sari Heitner Enschede, MD^9*, Rod A. Humerickhouse, MD, PhD⁹ and Cyrille Touzeau, MD^8*

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO
³Division of BMT, Winship Cancer Institute, Emory University, Atlanta, GA
⁴Division of Hematology/Oncology, Mayo Clinic College of Medicine, Scottsdale, AZ
⁵Maladies du Sang, Hopital Huriez, CHU Lille, Lille, France
⁶Hôpital A.Michallon, CHU Grenoble, Grenoble, France
⁷Hôpital Bretonneau Service Hématologie et Thérapies Cellulaires, Centre Régional de Cancérologie Henry Kaplan CHRU de Tours, Tours, France
⁸Nantes University Hospital, Hôtel Dieu, Nantes, France
⁹AbbVie Inc., North Chicago, IL

Andrew Spencer¹, Jacob P. Laubach, MD², Jeffrey A Zonder, MD³, Ashraf Z Badros, MD⁴, Simon Harrison, MD^5*, Amit Khot, MD^6*, Dharminder Chauhan, PhD⁷, Kenneth C. Anderson, MD⁸, Steven D Reich, MD^9*, Mohit Trikha, PhD^10* and Paul G. Richardson, MD¹¹

¹Myeloma Research Group, Alfred Hospital-Monash University, Melbourne, Australia
²Dana-Farber Cancer Institute, Boston, MA
³Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI
⁴Department of Medicine and Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD
⁵University of Melbourne, Peter MacCallum Cancer Center, Melbourne, Australia
⁶Clinical Haematology Research Fellow Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia
⁷Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁸Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁹Triphase Accelerator Corporation, San Diego, CA
¹⁰Triphase Accelerator, San Diego, CA
¹¹Division of Hematologic Malignancy, Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Frederic J. Reu, MD¹, Jason Valent, MD², Ehsan Malek, MD³, Ronald M. Sobecks, MD⁴, Beth M Faiman, PhD, RN, MSN, CNP, AOCN⁵, Kimberly Hamilton, CNP^6*, Jamie Elberson, RN^7*, Sherry Fada^1*, Hien K. Liu, MD⁴, Christy Samaras, DO⁵ and Mitchell R. Smith, MD, PhD⁴

¹Hematology & Oncology, Cleveland Clinic, Cleveland, OH
²Hematology & Oncology, Clevland Clinic, Cleveland, OH
³Division of Hematology and Oncology, Case Western Reserve University, Cleveland, OH
⁴Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁵Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
⁶Cleveland Clinic, Taussig Cancer Institute, Cleveland
⁷Hematology & Oncology, Cleveland Clinic, Cleveland

Xiaoyu Yan^1*, Pamela L Clemens^2*, Thomas Puchalski^2*, Sagar Lonial, MD^3,4, Henk M. Lokhorst⁵, Robert Z. Orlowski, MD, PhD⁶, Nedjad Losic^7*, Imran Khan^1*, Richard Jansson^2*, Tahamtan Ahmadi^2*, Kristen Lantz^2*, Juan Jose Perez Ruixo^8*, Honghui Zhou^2* and Xu Steven Xu^1*

¹Janssen Research & Development, LLC, Raritan, NJ
²Janssen Research & Development, LLC, Spring House, PA
³Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
⁴Winship Cancer Institute of Emory University, Department of Hematology and Medical Oncology, Atlanta, GA
⁵VU University Medical Center, Amsterdam, Netherlands
⁶University of Texas M.D. Anderson Cancer, Houston, TX
⁷Genmab A/S, Copenhagen, Denmark
⁸Janssen Research & Development, Beerse, Belgium

Andrzej Jakubowiak, MD, PhD¹, Jagoda Jasielec, MD², Cara A. Rosenbaum, MD¹, Jeffrey A Zonder, MD³, Craig E. Cole, MD⁴, Ajai Chari, MD⁵, Jennifer Nam^1*, Leonor A Stephens, PhD^1*, Kathryn McDonnell^1*, Rebecca Uribe^1*, Shaun Rosebeck, PhD¹, Tami Rashal, MD^6*, Hagop Youssoufian, MD^6*, Sarah Henry^6*, Sharon Shacham^6*, Michael Kauffman, MD, PhD⁶, Todd Zimmerman, MD¹ and Theodore Karrison, PhD^7*

¹University of Chicago Medical Center, Chicago, IL
²Northshore University Health System, Evanston, IL
³Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI
⁴Department of Medicine, Division of Hematology/Oncology, University of Michigan School of Medicine, Ann Arbor, MI
⁵Tisch Cancer Institute / Multiple Myeloma Program, Mount Sinai School of Medicine, New York, NY
⁶Karyopharm Therapeutics, Inc, Newton, MA
⁷University of Chicago, Chicago, IL

Kenshi Suzuki¹, Miho Kasuga, trainee^2*, Kanji Miyazaki, MD^1*, Sohsuke Meshitsuka, MD^1*, Yu ABE, MD^1*, Yumiko Yoshiki, MD, PhD^1* and Nobuhiro Tsukada, MD, PhD¹

¹Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan
²Dept. of Hematology, Keio University, Tokyo, Japan

Meletios A. Dimopoulos¹, Antonio Palumbo², Paolo Corradini³, Michele Cavo^4*, Michel Delforge⁵, Katja C. Weisel^6*, Enrique M. Ocio, MD, PhD^7*, Francesco Di Raimondo⁸, Markus Hansson^9*, Mathew Simcock^10*, Neil Miller^10*, Ana Slaughter^10*, Teresa Peluso^10*, Lars Sternas^11*, Mohamed H Zaki¹¹ and Philippe Moreau^12*

¹National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²University of Torino, Torino, Italy
³Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
⁴Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
⁵University Hospital Leuven, Leuven, Belgium
⁶Hematology & Oncology, Department of Medicine, University Hospital Tuebingen, Tuebingen, Germany
⁷University Hospital of Salamanca, Salamanca, Spain
⁸Department of Hematology, University of Catania, Catania, Italy
⁹Department of Hematology, Skåne University Hospital, Lund University, Lund, Sweden
¹⁰Celgene International Sàrl, Boudry, Switzerland
¹¹Celgene Corporation, Summit, NJ
¹²Nantes University Hospital, Hôtel‐Dieu, Nantes, France

Ajai Chari, MD¹, Hearn Jay Cho, MD, PhD¹, Siyang Leng, MD^2*, Amishi Dhadwal, BS^3*, Gillian Morgan^3*, Lisa La, MS/CCRP^4*, Katarzyna Garcia, MS / CCRP^3*, Crystle Carter, RN^5*, Donna Catamero^5*, Juliet Escalon^6*, Erika Florendo^6*, Nadege Stevens, RN^5*, Daniel Verina^6*, Moon-hee Yum, RN^5*, Jude Gullie, BA^3*, Elaine Chan, BS^3*, Sundar Jagannath, MD¹, Violetta V Leshchenko, PhD^7*, Alessandro Lagana, PhD^8*, Jingjing Qi^9*, Manishkumar Patel^10*, Kim-Schulze Seunghee^10* and Samir Parekh, MD¹¹

¹Tisch Cancer Institute / Multiple Myeloma Program, Mount Sinai School of Medicine, New York, NY
²Icahn School of Medicine at Mount Sinai, New York, NY
³Tisch Cancer Institute / Multiple Myeloma Program, Mount Sinai School of Medicine, New York
⁴Tisch Cancer Institute/ Multiple Myeloma Program, Mount Sinai School of Medicine, New York
⁵Mount Sinai Hospital, New York
⁶Ruttenberg Treatment Center, Mount Sinai Hospital, New York
⁷Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
⁸Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY
⁹Human Immune Monitoring Core, Icahn School of Medicine at Mount Sinai, New York, NY
¹⁰Mt Sinai School of Medicine, New York
¹¹Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, NY

Neeraj Gupta, PhD^1*, Michael J Hanley, PhD^1*, R. Donald Harvey, PharmD², Ashraf Z Badros, MD³, Brea C. Lipe, MD⁴, Vishal Kukreti⁵, Jesus G. Berdeja, MD⁶, Huyuan Yang, PhD^1*, Ai-Min Hui, MD, PhD¹, Xiaoquan Zhang, MD, PhD^1*, Karthik Venkatakrishnan, PhD^1* and Ajai Chari, MD⁷

¹Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
²Winship Cancer Institute, Emory University, Atlanta, GA
³Department of Medicine and Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD
⁴University of Kansas Clinical Research Center, Kansas City, KS
⁵University Health Network, Toronto, ON, Canada
⁶Sarah Cannon Cancer Center, Nashville, TN
⁷Mount Sinai Medical Center, New York, NY

Noopur S. Raje, MD¹, William Bensinger, MD^2*, Craig E. Cole, MD³, Sagar Lonial, MD^4,5, Sundar Jagannath, MD⁶, Carlos E. Arce-Lara, MD⁷, Jason Valent, MD⁸, Ashley E Rosko, MD⁹, Wael A. Harb, MD¹⁰, Irwindeep Sandhu, MD¹¹, Nizar J Bahlis, MD¹², Donna Reece¹³, Evangelos Terpos, MD¹⁴, Jeffrey Supko, PhD^15*, David Tamang, PhD^16*, Simon S Jones, PhD^16*, Catherine Wheeler, MD^16*, Robert J Markelewicz Jr., MD^16* and Paul G. Richardson¹⁷

¹Massachusetts General Hospital Cancer Center, Boston, MA
²Fred Hutchinson Cancer Research Center, Seattle, WA
³Department of Medicine, Division of Hematology/Oncology, University of Michigan School of Medicine, Ann Arbor, MI
⁴Winship Cancer Institute, Emory University, Atlanta, GA
⁵Winship Cancer Institute of Emory University, Department of Hematology and Medical Oncology, Atlanta, GA
⁶Hematology and Medical Oncology, Mount Sinai Hospital, New York, NY
⁷Medical College of Wisconsin, Milwaukee, WI
⁸Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
⁹Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
¹⁰Horizon Oncology Center, Lafayette, IN
¹¹Department of Medicine, Division of Hematology, University of Alberta, Edmonton, AB, Canada
¹²University of Calgary, Southern Alberta Cancer Research Institute, Calgary, AB, Canada
¹³Princess Margaret Cancer Centre, Toronto, ON, Canada
¹⁴Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
¹⁵Massachusetts General Hospital, Boston
¹⁶Acetylon Pharmaceuticals, Inc., Boston
¹⁷Dana-Farber Cancer Institute, Boston, MA

Jatin J. Shah, MD¹, Rafat Abonour, MD², Mohit Narang^3*, Jayesh Mehta⁴, Howard R. Terebelo⁵, Cristina J Gasparetto⁶, Kathleen Toomey^7*, James W Hardin^8*, Shankar Srinivasan^9*, Gail Larkins^9*, Yasir Nagarwala⁹ and Robert M. Rifkin¹⁰

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²Hematology/Oncology, Indiana University School of Medicine, Indianapolis, IN
³Maryland Oncology Hematology, Columbia, MD
⁴Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago
⁵Providence Cancer Institute, Southfield, MI
⁶Duke University Medical Center, Durham, NC
⁷Steeplechase Cancer Center, Robert Wood Johnson University Hospital, Somerville, NJ
⁸Arnold School of Public Health, University of South Carolina, Columbia, SC
⁹Celgene Corporation, Summit, NJ
¹⁰US Oncology Research and Rocky Mountain Cancer Centers, Denver, CO

Jesús F San Miguel¹, Vânia TM Hungria², Sung-Soo Yoon³, Meral Beksac, MD⁴, Meletios A. Dimopoulos⁵, Ashraf Elghandour, MD^6*, Wieslaw W. Jedrzejczak, MD^7*, Andreas Guenther, MD⁸, Thanyaphong Na Nakorn, MD^9*, Noppadol Siritanaratkul¹⁰, Robert L. Schlossman, MD¹¹, Jian Hou, MD, PhD^12*, Philippe Moreau^13*, Sagar Lonial, MD^14,15, Jae Hoon Lee^16*, Hermann Einsele, MD¹⁷, Monika Sopala, PhD^18*, Bourras-Rezki Bengoudifa, MS^18*, Claudia Corrado, MD^18*, Florence Binlich^19* and Paul G. Richardson, MD¹¹

¹Clínica Universidad de Navarra-CIMA, Pamplona, Spain
²Santa Casa de Misericórdia de São Paulo, Sao Paulo, Brazil
³Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea
⁴Ankara University Faculty of Medicine Department of Hematology, Ankara, Turkey
⁵National and Kapodistrian University of Athens, Athens, Greece
⁶Alexandria University, Qesm Bab Sharqi, Egypt
⁷Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland
⁸University of Kiel, Kiel, Germany
⁹Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand
¹⁰Department of Pediatrics and Internal Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
¹¹Dana-Farber Cancer Institute, Boston, MA
¹²Department of Hematology, The Myeloma & Lymphoma Center, Changzheng Hospital, The Second Military Medical University, Shanghai, China
¹³Department of Hematology, Nantes University Hospital, Nantes, France
¹⁴Winship Cancer Institute, Emory University, Atlanta, GA
¹⁵Winship Cancer Institute of Emory University, Department of Hematology and Medical Oncology, Atlanta, GA
¹⁶Gachon University Gil Medical Center, Incheon, South Korea
¹⁷Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany
¹⁸Novartis Pharma AG, Basel, Switzerland
¹⁹Novartis Pharma SAS, Rueil-Malmaison, France

Mercedes Gironella^1*, Juan Bergua^2*, Carlos Fernández de Larrea^3*, Fernando Escalante^4*, Maria González^5*, Carmen Martínez Chamorro^6*, Aurelio López^7*, E Pérez-Persona^8*, Juan José Lahuerta^9*, Nieves Somilinos^10*, Alfonso Soler^11*, Yolanda Gonzalez^12*, Alexia Suárez Cabrera^13*, Abelardo Barez^14*, Valentin Cabañas^15*, Antonia Sampol^16*, Ana Pilar Gonzalez^17*, Giselle Lostaunau^18*, David Vilanova^18* and Adrian Alegre¹⁹

¹Hospital Universitari Vall dHebron, Barcelona, Spain
²Hospital San Pedro de Alcántara, Cáceres, Spain
³Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain
⁴Hospital De Leon, Leon, France
⁵Hospital de Cabuenes - SESPA, Gijon, Spain
⁶Hospital Universitario Quiron Madrid, Madrid, Spain
⁷Hospital Arnau de Vilanova-Valencia, Valencia, Spain
⁸Hospital Universitario de Alava, A Coruna, Spain
⁹Hospital 12 de Octubre, Madrid, Spain
¹⁰Hospital Universitario de Getafe, Madrid, Spain
¹¹Hospital Universitari Parc Tauli Sabadell, Barcelona, Spain
¹²Institut Catala d' Oncologia Girona. Hospital Universitari Josep Treuta, Girona, Spain
¹³Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
¹⁴Hospital Nuastra Señora Sonsoles, Ávila, Spain
¹⁵Hospital Clíníco Universitario Virgen de la Arrixaca, Madrid, Spain
¹⁶Hematology, Hospital Son Espases, Palma de Mallorca, Spain
¹⁷Hospital Universitario Central de Asturias, Oviedo, Spain
¹⁸Celgene SLU, Madrid, Spain
¹⁹Hematology Department, Hospital Universitario de La Princesa, Madrid, Spain

Tomer M Mark, MD, MSc¹, Angelique Boyer^2*, Sujitha Yadlapati, MBBS^2*, Adriana C Rossi, MD^2*, Roger N Pearse, MD, PhD^1*, Karen Pekle, NP^2*, Arthur Perry, PA^2*, Kathleen Pogonowski, RN^2*, Ekta Aneja, MD^2*, Linda Tegnestam, RN^2*, David Jayabalan, BSMS, MSc^1*, Scott Ely, MD, MPH³, Morton Coleman, MD², Xiangao Huang, PhD^4*, Maurizio Di Liberto, PhD⁴, Selina Chen-Kiang, PhD⁴ and Ruben Niesvizky, MD¹

¹Center of Excellence for Lymphoma and Myeloma, Weill Cornell Medical College, New York, NY
²Division of Hematology / Oncology, Weill Cornell Medical College, New York, NY
³Department of Pathology, Weill Cornell Medical College, New York, NY
⁴Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY

Maximilian Merz, MD^1*, Hans-Juergen Salwender, MD^2*, Mathias Haenel, MD^3*, Uta Bertsch, MD^4*, Christina Kunz^5*, Thomas Hielscher^5*, Igor W. Blau, MD^6*, Christof Scheid, MD PhD⁷, Elias Karl Mai, MD^8*, Dirk Hose, MD¹, Bärbel Schurich^9*, Markus Munder, MD^10*, Peter Brossart, MD¹¹, Christian Gerecke, MD^12*, Hans Walter Lindemann, MD^13*, Matthias Zeis, MD^14*, Katja C. Weisel^15*, Jan Duerig, MD^16* and Hartmut Goldschmidt, MD⁸

¹Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
²Asklepios Klinik Altona, Hamburg, Germany
³Klinikum Chemnitz, Chemnitz, Germany
⁴Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
⁵German Cancer Research Center, Heidelberg, Germany
⁶Internal Medicine, Charité University Medicine Berlin, Berlin, Germany
⁷Department of Internal Medicine I, Center of Integrated Oncology (CIO), CECAD, University of Cologne, Cologne, Germany
⁸Internal Medicine V, University Clinic Heidelberg, Heidelberg, Germany
⁹University Hospital Heidelberg, Heidelberg, Germany
¹⁰University Hospital of Mainz, Mainz, Germany
¹¹Internal Medicine III, Oncology, Hematology and Rheumatology, University Clinic Bonn, Bonn, Germany
¹²Hematology and Oncology, Helios-Hospital Berlin Buch, Berlin, Germany
¹³KKH Hagen, Hagen, Germany
¹⁴Asklepios Klinik St. Georg, Hamburg, Germany
¹⁵Department of Hematology, Oncology, Immunology, Rheumatology and Pulmonology, University Hospital of Tuebingen, Tuebingen, Germany
¹⁶Department of Haematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

Suzanne Trudel, MD¹, Darrell White, MD², Martin Gyger, MD³, Jonahtan Kaufmann, MD^4*, Andrzej Jakubowiak, MD, PhD^5,6, Engin Gul, BSc^7*, Lisa W Le, MSc^8*, Zhihua Li^9*, Donna Reece¹, Vishal Kukreti, MD, FRCPC¹ and Richard LeBlanc¹⁰

¹Princess Margaret Cancer Centre, Toronto, ON, Canada
²Dalhousie University, Queen Elizabeth II Health Sciences Ctr., Halifax, NS, Canada
³Jewish General Hospital, Montreal, QC, Canada
⁴Winship Cancer Institute, Emory University, Atlanta, GA
⁵Multiple Myeloma Research Consortium, Norwalk, CT
⁶University of Chicago Medical Center, Chicago, IL
⁷University Health Network-PMH, Toronto, ON, Canada
⁸Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁹Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
¹⁰Division of Hematology and Medical Oncology, Department of Medicine, Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, QC, Canada

R. Donald Harvey¹, Yaozhu J. Chen, MPA^2*, Jan Lethen^3* and Maya Mahue^2*

¹Winship Cancer Institute, Emory University, Atlanta, GA
²Onyx Pharmaceuticals, Inc., an Amgen subsidiary, South San Francisco, CA
³Amgen, Thousand Oaks

Hang Quach, MD^1*, Simon Harrison, MD^2*, Liam J. Fernyhough, MB, BS, BMedSci^3*, Ross Alistair Henderson, PhD, FRACP, FRCPA^4*, Gillian Corbett, MD FRACP FRCPA^5*, Peter Browett, MBChB, FRACP, FRCPA⁶, Hilary Anne Blacklock, FRACP^7*, Craig Underhill, MD⁸, Paul Cannell, MD⁹, Judith Trotman, MBChB¹⁰, Emma Link, PhD^11*, Linda Cowan^11*, Jack S Li^12*, Meletios A. Dimopoulos¹³ and H.Miles Prince, MD¹⁴

¹University of Melbourne, St. Vincent's Hospital, Victoria, Australia
²University of Melbourne, Peter MacCallum Cancer Center, Melbourne, Australia
³Weill Cornell medical College, -, Qatar
⁴North Shore Hospital, Auckland, New Zealand
⁵Tauranga Hospital, Tauranga, New Zealand
⁶University of Auckland, Auckland, New Zealand
⁷Middlemore Hospital, Auckland, New Zealand
⁸University of NSW, Border Medical Oncology, Albury, Australia
⁹Royal Perth Hospital, Perth, Australia
¹⁰Department of Hematology, Concord Repatriation General Hospital, Concord, NSW, Australia
¹¹Peter MacCallum Cancer Centre, Melbourne, Australia
¹²Celgene Corp., -
¹³National and Kapodistrian University of Athens, Athens, Greece
¹⁴University of Melbourne, Peter MacCallum Cancer Centre, Melbourne, Australia

Misty Jenkins, PhD^1*, Rachael Canfield, BSc^1*, Michael Robbins, BS^2*, David S. Ritchie, MD, PhD³, Joe Trapani^1* and Paul Neeson, BSc, PhD^4*

¹Peter MacCallum Cancer Centre, Melbourne, Australia
²Bristol-Myers Squibb, Princeton, NJ
³Royal Melbourne Hospital, Parkville, Australia
⁴Cancer Immunology Research, Peter MacCallum Cancer Center, Melbourne, Australia

Ivan M. Borrello, MD¹, Kimberly Noonan, PhD, MPH^2*, Carol Ann Huff³, Anna Ferguson, BSN, RN^4*, Amy Sidorski, CRNP^4*, Lakshmi Rudraraju^5*, Raffaello Cimbro, MS^6* and Luigi Marchionni, MD, PhD^7*

¹Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD
²Johns Hopkins School of Medicine, Baltimore, MD
³Johns Hopkins University, Baltimore, MD
⁴Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
⁵Oncology, Johns Hopkins University, Baltimore, MD
⁶Department of Rheumatology, Johns Hopkins University, Baltimore, MD
⁷Oncology, Johns Hopkins Universityi, Baltimore, MD

Thierry Facon¹, Cyrille Hulin^2*, Meletios A. Dimopoulos³, Andrew Belch⁴, Nathalie Meuleman⁵, Mohamad Mohty^6*, Wen-Ming Chen^7*, Kihyun Kim⁸, Elena Zamagni^9*, Paula Rodriguez-Otero, MD, PhD^10*, William Renwick^11*, Christian Rose¹², Adrian Tempescul^13*, Antonio Palumbo¹⁴, Shien Guo^15*, Michael Sturniolo^16*, Annette Ervin-Haynes¹⁶ and Jean-Paul Fermand¹⁷

¹Maladies du Sang, Hôpital Claude Huriez, CHRU Lille, Lille, France
²CHU BORDEAUX, Bordeaux, France
³National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁴Cross Cancer Institute, Edmonton, AB, Canada
⁵Department of Hematology, Jules Bordet Insitute, Université Libre de Bruxelles, Brussels, Belgium
⁶Department of Haematology, Saint Antoine Hospital, Paris, France
⁷Beijing Chaoyang Hospital, Beijing, China
⁸Sungkyunkwan University, Samsung Medical Center, Seoul, South Korea
⁹Azienda Ospedaliero-Universitaria, Malpighi, Bologna, Italy
¹⁰Clínica Universidad de Navarra, Pamplona, Spain
¹¹Western Health, St Albans, Australia
¹²Dept. of Hematology, Hopital St. Vincent, Lille, France
¹³Hematology Department, CHU Brest, Brest, France
¹⁴University of Torino, Torino, Italy
¹⁵Evidera, Boston, MA
¹⁶Celgene Corporation, Summit, NJ
¹⁷Service d'Immuno-Hematologie, Hopital Saint-Louis, APHP, Paris, France

Jin Lu¹, Jae Hoon Lee², Shang-Yi Huang^3*, Lugui Qiu^4*, Je-Jung Lee⁵, Ting Liu⁶, Sung-Soo Yoon⁷, Kihyun Kim⁸, Zhi Xiang Shen^9*, HyeonSeok Eom¹⁰, Wenming Chen^11*, Chang-Ki Min^12*, Hyo Jung Kim^13*, Jeong Ok Lee^14*, Jae Yong Kwak^15*, Wai Yiu^16*, Guang Chen^16*, Annette Ervin Haynes^16*, Cyrille Hulin^17* and Thierry Facon¹⁸

¹Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China
²Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, South Korea
³Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
⁴Blood Disease Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, China
⁵Department of Hematology-Oncology,Chonnam National University Hwasun Hospital, Hwasun, South Korea
⁶Department of Hematology, West China Hospital, Sichuan University, Chengdu, China
⁷Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea
⁸Sungkyunkwan University, Samsung Medical Center, Seoul, South Korea
⁹Ruijin Hospital, Shanghai Second Medical University, Shanghai, China
¹⁰National Cancer Center, Goyang-si, Gyeonggi-do, South Korea
¹¹Beijing Chao-Yang Hospital, Beijing, China
¹²The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, South Korea
¹³Hallym University Sacred Heart Hospital, Anyang, South Korea
¹⁴Seoul National University Bundang Hospital, Seongnam, South Korea
¹⁵Chonbuk National University Hospital 42, Jeonju, South Korea
¹⁶Celgene Corporation, Summit, NJ
¹⁷Service Hematologie, CHRU Hopitaux de Brabois, Vandoeuvre cedex, France
¹⁸Maladies du Sang, Hôpital Claude Huriez, CHRU Lille, Lille, France

Andrew J. Yee, MD¹, Jacob P. Laubach, MD², Ajay K. Nooka, MD, MPH³, Elizabeth K. O'Donnell, MD¹, Edie A. Weller, PhD^4*, Nicole R. Couture, BSN, RN^1*, Ellen E. Wallace, BA^1*, Jill N. Burke, NP^1*, Cynthia C. Harrington, NP^1*, Marie Puccio-Pick, MS^5*, Abderrahmane Laadem, MD⁵, Matthew L. Sherman, MD⁶ and Noopur S. Raje, MD¹

¹Massachusetts General Hospital Cancer Center, Boston, MA
²Dana-Farber Cancer Institute, Boston, MA
³Division of BMT, Winship Cancer Institute, Emory University, Atlanta, GA
⁴Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
⁵Celgene Corporation, Summit, NJ
⁶Acceleron Pharma, Cambridge, MA

Efstathios Kastritis, MD^1*, Evangelos Terpos¹, Nikolaos Kanellias^1*, Vasiliki Babali^1*, Spyridon Orfanopoulos^1*, Ursula Koloventzou^1*, Maria Gavriatopoulou^1*, Despoina Fotiou^1*, Dimitrios Ziogas^1*, Eftychia Kafantari^1*, Stavroula Giannouli^2* and Meletios A. Dimopoulos³

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²Second Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
³National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Maria-Victoria Mateos^1,2, Norma C Gutierrez^2*, María-Luisa Martín^3*, Joaquín Martínez-López, MD, PhD^4*, Miguel T Hernandez^5*, Rafael Martinez, MD PhD^6*, Laura Rosiñol, MD PhD^7*, Enrique M. Ocio, MD, PhD^8*, Ana Isabel Teruel, MD^9*, Albert Oriol, MD PhD^10*, Juan Jose Bargay^11*, Enrique Bengoechea^12*, Yolanda Gonzalez, MD^13*, Jaime Perez De Oteyza^14*, Mercedes Gironella^15*, Cristina Encinas^16*, Jesus Martin^17*, Carmen Cabrera^18*, Bruno Paiva, PhD^19*, Noemi Puig, MD, PhD^20*, Joan Blade, MD PhD⁷, Juan José Lahuerta^3* and Jesus San Miguel, MD PhD^21*

¹Hematology Department, University Hospital of Salamanca/IBSAL, Salamanca, Spain
²Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), Salamanca, Spain
³Hospital 12 de Octubre, Madrid, Spain
⁴Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain
⁵Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain
⁶Hospital Universitario San Carlos, Madrid, Spain
⁷Hospital Clinic de Barcelona, Barcelona, Spain
⁸University Hospital of Salamanca, Salamanca, Spain
⁹Hospital Clinico de Valencia, Valencia, Spain
¹⁰Institut Català d’Oncologia, Hospital Germans Trias i Pujol, Barcelona, Spain
¹¹Hospital Sont Llatzer, Palma de Mallorca, Spain
¹²Hospital de Donostia, San Sebastian, Spain
¹³Haematology, Institut d’Oncologia Dr Josep Trueta de Girona, Girona, Spain
¹⁴Hospital Universitario Sanchinarro, Madrid, Spain
¹⁵Hospital Universitari Vall dHebron, Barcelona, Spain
¹⁶Instituto de Investigacion Sanitaria Gregorio Marañón (IiSGM), Hospital General Universitario Gregorio Marañón,, Madrid, Spain
¹⁷Hospital Universitario Virgen del Rocío, Sevilla, Spain
¹⁸Hospital San Pedro de Alcántara, Cáceres, Spain
¹⁹Department of Hematology and Immunology, Clinica Universidad de Navarra, Pamplona, Spain
²⁰Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain
²¹Clinical Universidad de Navarra, Pamplona, Spain

Elena Cherkasova, PhD^1*, Luis Espinoza, MD, PhD^2,3*, Ritesh Kotecha⁴, Robert N. Reger, B.S.^5*, Maria Berg^4*, Georg Aue⁴, Ricardo M. Attar, PhD⁶, A Kate Sasser^7*, Mattias Carlsten, M.D., Ph.D.^5* and Richard W. Childs, M.D.⁴

¹NHLBI, National Heart Lung and Blood Institute, NIH, Bethesda, MD
²Kanazawa University, kanazawa, Japan
³Kanazawa University, Kanazawa, Japan
⁴National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD
⁵National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
⁶Janssen Research & Development, L.L.C., Spring House, PA
⁷Janssen Research & Development, LLC, Spring House, PA

Hélène Demarquette^1*, Stéphanie Guidez^1*, Artur J. Jurczyszyn, MD, PhD^2*, Denis Caillot^3*, Brigitte Pegourie, MD^4*, Marie Lorraine Chretien^5*, Charles Lancesseur^6*, Lionel Karlin^7*, Cristina M. Joao, MD, PhD^8*, Claire Bories^1*, Laurence Legros, MD^9*, Laurent Garderet, MD¹⁰, Souhila Ikhlef^11*, Martine Escoffre^12*, Bruno Royer, MD^13*, Laurent Voillat^14*, Cyrille Hulin^15*, Anne Banos, MD^16*, Eric G. Voog, MD¹⁷, Anne-Marie Stoppa, MD¹⁸, Lofti Benboubker^19*, Niels Abildgaard, MD, Professor²⁰, Katell Le Du^21*, Philippe Moreau^22*, Thierry Facon¹, Sonja Zweegman, MD, PhD²³, Margaret MACRO, MD^24*, Francesca Gay^25*, Evangelos Terpos²⁶ and Xavier Leleu, MD, PhD^1,27

¹Maladies du Sang, Hôpital Claude Huriez, CHRU Lille, Lille, France
²Department of Hematology, Cracow University Hospital, Krakow, Poland
³Hôpital du Bocage, Dijon, France
⁴Hôpital A.Michallon, CHU Grenoble, Grenoble, France
⁵CHRU Dijon, Dijon, France
⁶CHU Caen, Caen, France
⁷Service d'Hématologie, Centre Hospitalier Lyon Sud, Pierre Bénite, France
⁸Hematology department, Instituto Português de Oncologia de Lisboa, Lisbon, Portugal
⁹Hematology department, Hopital Archet 1, CHU Nice, Nice, France
¹⁰Hôpital Saint Antoine, Paris, France
¹¹Département d’hématologie, Hôpital Saint Antoine, Paris, France
¹²CHU Rennes, Rennes, France
¹³Hematology, Centre Hospitalier Universitaire, Amiens, France
¹⁴Service Hemato-Oncologie, Centre Hospitalier QWillian Morey, Chalon-sur-Saone, France
¹⁵Service Hematologie, CHRU Hopitaux de Brabois, Vandoeuvre cedex, France
¹⁶Hematology Department, CH Cote basque, Bayonne, France
¹⁷Hematology Department, Le Mans, Centre Jean Bernard, Le Mans, France
¹⁸Institut Paoli Calmettes, Marseille, France
¹⁹CHU Tours Hopital Bretonneau, Tours, France
²⁰Department of Hematology, Odense University Hospital, Odense, Denmark
²¹CENTRE JEAN BERNARD, LE MANS, France
²²Nantes University Hospital, Hôtel‐Dieu, Nantes, France
²³Department of Hematology, VUMC, Amsterdam, Netherlands
²⁴CHU Caen, CAEN, France
²⁵Myeloma Unit, Division of Hematology, University of Torino, A.O.U. S. Giovanni Battista, Torino, Italy
²⁶Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece
²⁷Service d'hématologie et Thérapie cellulaire, Hopital La Mileterie, Poitiers, France

Ajay K. Nooka, MD, MPH¹, Michael Wang, MD², Andrew J. Yee, MD³, Sheeba K. Thomas, MD⁴, Elizabeth K. O'Donnell, MD³, Jatin J. Shah, MD⁵, Jonathan L. Kaufman, MD¹, Sagar Lonial, MD^6,7, Paul G. Richardson, MD⁸ and Noopur S. Raje, MD³

¹Division of BMT, Winship Cancer Institute, Emory University, Atlanta, GA
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Massachusetts General Hospital Cancer Center, Boston, MA
⁴Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Winship Cancer Institute, Emory University, Atlanta, GA
⁷Winship Cancer Institute of Emory University, Department of Hematology and Medical Oncology, Atlanta, GA
⁸Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Shenmiao Yang, MD^1*, Aijun Liu, MD^2*, Yuping Zhong, MD^3*, Xiaojun Huang, M.D Ph.D⁴, Wenming Chen, MD^5* and Jin Lu⁶

¹Peking University Institute of Hematology, Peking University People's Hospital, Beijing, China
²Eastern center of Department of Hematology, Beijing Chaoyang Hospital, Beijing, China
³Western center of Department of Hematology, Beijing Chaoyang Hospital, Beijing, China
⁴Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
⁵Department of Hematology, Beijing Chaoyang Hospital, Beijing, China
⁶Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China

Maxim V. Solovev, MD, PhD^1*, Larisa P. Mendeleeva, MD, PhD^1*, Olga S. Pokrovskaya, MD, PhD^1*, Eduard Gemdzhian, PhD^2*, Elena Volodicheva^3*, Lyudmila V. Anchukova, MD, PhD^4*, Svetlana N. Menshakova, MD^5*, Svetlana M. Osyunikhina, MD^6*, Vladimir V. Voytsekhovski, MD, PhD^7* and Valeri G. Savchenko, MD, PhD, Prof.⁸

¹Department of high-dose chemotherapy, National Research Center for Hematology, Moscow, Russia
²Biostatistics, National Research Center for Hematology, Moscow, Russia
³Tula Regional Clinical Hospital, Tula, Russia
⁴Regional Clinical Hospital, Vologda, Russia
⁵Regional Clinical Hospital, Tver, Russia
⁶Regional Clinical Hospital, Saransk, Russia
⁷Regional Clinical Hospital, Blagoveshchensk, Russia
⁸National Research Center for Hematology, Moscow, Russia

Amit Kumar Mitra, PhD^1*, Ujjal Mukherjee, PhD^2*, Taylor Harding^1*, Holly Stessman, PhD^1*, Ying Li^3*, Jen Jin^4*, Shaji K Kumar, MD⁵, S. Vincent Rajkumar⁵ and Brian G Van Ness, PhD¹

¹Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN
²School of Statistics, University of Minnesota, Minneapolis, MN
³Bioinformatics Core, Center for Individualized Medicine, Mayo Clinic, Rochester, MN
⁴Medical Genome Facility Gene Expression Core, Mayo Clinic, Rochester, MN
⁵Division of Hematology, Mayo Clinic, Rochester, MN

Stuart D Russell^1*, Alexander Lyon^2*, Daniel J. Lenihan, MD^3*, Philippe Moreau^4*, Douglas Joshua⁵, Wee-Joo Chng⁶, Antonio Palumbo⁷, Hartmut Goldschmidt⁸, Roman Hájek⁹, Thierry Facon¹⁰, Heinz Ludwig¹¹, Ludek Pour, MD^12*, Ruben Niesvizky¹³, Albert Oriol, MD PhD^14*, Laura Rosiñol, MD PhD^15*, Aleksandr Suvorov^16*, Gianluca Gaidano¹⁷, Vesselina Goranova-Marinova^18*, Heidi H. Gillenwater¹⁹, Nehal Mohamed^19*, Shibao Feng^19* and Meletios A. Dimopoulos²⁰

¹Johns Hopkins Hospital, Baltimore, MD
²Royal Brompton Hospital and Imperial College London, London, United Kingdom
³Vanderbilt University Medical Center, Nashville, TN
⁴University of Nantes, Nantes, France
⁵Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
⁶National University Cancer Institute, National University Health System, Singapore and Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
⁷University of Torino, Torino, Italy
⁸Heidelberg Medical University, Heidelberg, Germany
⁹University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
¹⁰CHRU Lille Hôpital Claude Huriez, Lille, Lille, France
¹¹Wilhelminen Cancer Research Institute, Wilhelminenspital, Vienna, Austria
¹²University Hospital Brno, Brno, Czech Republic
¹³Weill Cornell Medical College/New York Presbyterian Hospital, New York, NY
¹⁴Institut Català d’Oncologia, Hospital Germans Trias i Pujol, Barcelona, Spain
¹⁵Hospital Clinic de Barcelona, Barcelona, Spain
¹⁶First Republican Clinical Hospital of Udmurtia, Ishevsk, Russia
¹⁷Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
¹⁸University Multiprofile Hospital for Active Treatment Sveti Georgi, Plovdiv, Bulgaria
¹⁹Onyx Pharmaceuticals, Inc., an Amgen subsidiary, South San Francisco, CA
²⁰National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Efstathios Kastritis, MD^1*, Evangelos Terpos¹, Maria Roussou^1*, Vassilis Koutoulidis^2*, Stavroula Giannouli^3*, Maria Gavriatopoulou^1*, Magdalini Migkou^1*, Evangelos Eleutherakis-Papaiakovou^1*, Despoina Fotiou^1*, Dimitrios Ziogas^1*, Ioannis Panagiotidis^1*, Despoina Kalapanida^1*, Eirini Katodritou^4*, Kostas Konstantopoulos^5*, Lia A. Moulopoulos^2* and Meletios A. Dimopoulos⁶

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²First Department of Radiology, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
³Second Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁴Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece
⁵Department of Hematology, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁶National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Ebba K Lindqvist, MD^1*, Sigrún H. Lund, PhD^2*, Rene Costello^3*, Debra Burton^3*, Neha S Korde, MD^4,5, Sham Mailankody, MBBS^3*, Vilmundur Gudnason, MD, PhD^6,7*, Gudny Eiriksdottir^7*, Leonore Launer, PhD^8*, Tamara B Harris, MD^8*, Malin Hultcrantz, MD PhD¹, Ola Landgren, MD, PhD^1,5, Sigurdur Y Kristinsson, MD, PhD^1,9 and Magnus Bjorkholm, MD, PhD¹

¹Department of Medicine, Division of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden
²Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland
³Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD
⁴Department of Medicine, Myeloma Service, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁵Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Faculty of Medicine, University of Iceland, Reykjavik, Iceland
⁷Icelandic Heart Association, Kopavogur, Iceland
⁸National Institute on Aging, National Institutes of Health (NIH), Bethesda, MD
⁹University of Iceland, Faculty of Medicine, Reykjavik, Iceland

Hua Jiang, MD PhD^1*, Chirag Acharya, MD^1*, Gang An Gang An, MD PhD^1*, Xiaoyan Feng, MD^2*, Zhili Song³, Guang Yang, PhD³, Francisco Adrian^3*, Lugui Qiu, MD⁴, Paul Richardson, MD^1*, Nikhil C. Munshi, MD⁵, Yu-Tzu Tai, PhD⁶ and Kenneth C Anderson, MD⁷

¹Harvard Medical School, the Jerome Lipper Center for Multiple Myeloma Research, Dana-Farber Cancer Institute, Boston, MA
²State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China
³Sanofi Oncology, Cambridge, MA
⁴Institute of Hematology, Tianjin, China
⁵Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA
⁶Harvard Medical School, the Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA
⁷The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Xu Steven Xu^1*, Xiaoyu Yan^1*, Thomas Puchalski^2*, Sagar Lonial, MD^3,4, Henk M. Lokhorst⁵, Peter M. Voorhees, MD⁶, Kevin Liu^1*, Imran Khan^1*, Richard Jansson^2*, Tahamtan Ahmadi^2*, Juan Jose Perez Ruixo^7*, Honghui Zhou^2* and Pamela L Clemens^2*

¹Janssen Research & Development, LLC, Raritan, NJ
²Janssen Research & Development, LLC, Spring House, PA
³Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA
⁴Winship Cancer Institute of Emory University, Department of Hematology and Medical Oncology, Atlanta, GA
⁵VU University Medical Center, Amsterdam, Netherlands
⁶Division of Hematology/Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC
⁷Janssen Research & Development, Beerse, Belgium

Ka Tat Siu, PhD¹, Homare Eda, MD, PhD^1*, Loredana Santo, MD^2*, Janani Ramachandran, MA^1*, Miroslav Koulnis, PhD^1*, Jennifer Mertz, PhD^3*, Robert J. Sims, PhD^3*, Michael Cooper, MD³ and Noopur S. Raje, MD²

¹Massachusetts General Hospital Cancer Center, Boston, MA
²Massachusetts General Hospital, Boston, MA
³Constellation Pharmaceuticals, Cambridge, MA

Irene M. Ghobrial, MD¹, Kenneth H. Shain, MD^2*, Jacob Laubach, MD^3*, Patrick Henrick^3*, James Vredenburg, MD^4*, Pamela Crilley, MD^5*, Michael Constantine, MD^6*, Caroline Block, MD^7*, Frank G. Basile, MD^8*, Joseph Cappuccio^3*, Abdel Kareem Azab, BPharm, PhD⁹, Emily Lai^3*, Aaron Caola^3*, Ranjit Banwait^3*, Alexandra Savell^3*, Nikhil C. Munshi, MD¹⁰, Claudia E. Paba-Prada, MD¹¹, Robert L. Schlossman, MD¹², Stacey Chuma, BSN^11*, Kimberly Noonan, NP^3*, Kenneth C. Anderson, M.D¹³ and Paul G. Richardson, MD¹¹

¹Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
²Moffitt Cancer Center, Florida
³Dana-Farber Cancer Institute, Boston
⁴St. Francis Care, Hartford
⁵Eastern Regional Medical Center, Philadelphia
⁶Dana-Farber Cancer Institute, Milford
⁷Newton Wellesley Hospital, Newton
⁸Cape Cod Hospital, Cape Cod
⁹Department of Radiation Oncology, Cancer Biology Division, Washington University in Saint Louis School of Medicine, Saint Louis, MO
¹⁰Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Boston, MA
¹¹Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
¹²Dana-Farber Cancer Institute, Boston, MA
¹³Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Nikoletta Lendvai, MD PhD^1,2, Sean Devlin, PhD^3*, Minal Patel, BA^4*, Kristina Marie Knapp^5*, Daniel Ekman^6*, Ida Grundberg^6*, David J Chung, MD PhD^2,7, Hani Hassoun, MD^2,8, Guenther Koehne, MD PhD⁷, Alexander M. Lesokhin, MD^2,8, Heather Landau, MD^2,9, Sergio A. Giralt, MD^7,10, Neha S Korde, MD^2,8 and Ola Landgren, MD, PhD^8,11

¹Memorial Sloan-Kettering Cancer Center, New York, NY
²Weill Cornell Medical College, New York, NY
³Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Hematologic Oncology Tissue Bank, Memorial Sloan Kettering Cancer Center, New York
⁵Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York
⁶Olink Bioscience, Uppsala, Sweden
⁷Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁹Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY
¹⁰Weill Cornell Medical College, Cornell University, New York, NY
¹¹Department of Medicine, Weill Cornell Medical College, New York, NY

Tomer M Mark, MD, MSc¹, Sujitha Yadlapati, MBBS^2*, Lyubov Neglyad^2*, Jennifer Bourke, RN^2*, David Jayabalan, BSMS, MSc^1*, Adriana C Rossi, MD^2*, Roger N Pearse, MD, PhD^1*, Arthur Perry, PA^2*, Karen Pekle, NP^2*, Kathleen Pogonowski, RN^2*, Linda Tegnestam, RN^2*, Xiangao Huang, PhD^3*, Maurizio Di Liberto, PhD³, Scott Ely, MD, MPH⁴, Morton Coleman, MD², Selina Chen-Kiang, PhD³ and Ruben Niesvizky, MD¹

¹Center of Excellence for Lymphoma and Myeloma, Weill Cornell Medical College, New York, NY
²Division of Hematology / Oncology, Weill Cornell Medical College, New York, NY
³Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY
⁴Department of Pathology, Weill Cornell Medical College, New York, NY

Isobel Ramsay^1*, Dunnya De-silva^2*, Sarah Worthington^2*, Mark Coyne^3*, Ashutosh Wechalekar³ and Paul D Griffiths^1*

¹Virology Department, Royal Free Hospital, London, United Kingdom
²Haematology Department, Royal Free Hospital, London, United Kingdom
³University College London Medical School, National Amyloidosis Centre, London, United Kingdom

Alexander Keller, MD^1*, Johannes M. Waldschmidt, MD^1*, Dagmar Wider^2*, Dorothee Jakobs^1*, Mandy Möller^3*, Heike Reinhardt^1*, Milena Pantic, PhD^1*, Olga Grishina, M.D.^4*, Gabriele Ihorst, PhD^4*, Annette M May, MD^5*, Anna Frey, MD^5*, Ulrike Kohlweyer, PhD^1*, Justus Duyster, MD, PhD^1*, Manfred Jung, PhD^6*, Monika Engelhardt, MD, PhD¹ and Ralph Wäsch, MD, PhD^1*

¹Department of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Germany
²Dept. of Hematology, Oncology and Stem Cell Transplantation, University Medical Center, Freiburg, Germany
³Department of Hematology&Oncology+Comprehensive Cancer Center Freiburg (CCCF), University of Freiburg Medical Center, Freiburg, Germany
⁴Clinical Trials Unit, University of Freiburg Medical Center, Freiburg, Germany
⁵Institute of Pathology, University of Freiburg Medical Center, Freiburg, Germany
⁶Institute of Pharmaceutical Sciences, University of Freiburg Medical Center, Freiburg, Germany

Christopher P. Venner, MD¹, Nizar J Bahlis, MD², Paola Neri, MD, PhD², Irwindeep Sandhu, MD³, Peter Duggan, MD⁴, Andrew Belch, MD¹, Joanne D Hewitt, RN, BSN, NP^5*, Linda M. Pilarski, PhD¹, Tatiana Nikitina^1* and Victor H Jimenez-Zepeda, MD⁶

¹Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
²University of Calgary, Southern Alberta Cancer Research Institute, Calgary, AB, Canada
³Department of Medicine, Division of Hematology, University of Alberta, Edmonton, AB, Canada
⁴Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada
⁵Nursing, Cross Cancer Institute, Edmonton, AB, Canada
⁶University of Calgary, Division of Hematology, Calgary, AB, Canada

Eli Muchtar, MD^1*, Hila Magen, MD^1*, Gilad Itchaki, MD^1*, Amos Cohen, MD¹, Raama Rosenfeld^2*, Tzippy Shochat, MSc^3*, Ran Kornowski, MD^4*, Zaza Iakobishvili, MD^4* and Pia Raanani, MD¹

¹Institute of Hematology, Davidoff cancer center, Beilinson Hospital, Rabin Medical Center, Petah-Tikva and Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel, Petah Tikva, Israel
²Immunology department, Rabin medical center, Petah Tikva, Israel
³Statistical unit, Research department, Rabin medical center, Petah Tikva, Israel
⁴Cardiology Department, Rabin Medical Center, Petah-Tikva, Israel and Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel, Petah tikva, Israel

Noopur Raje¹, Ian Chau^2*, David M. Hyman³, Vincent Ribrag^4*, Jean-Yves Blay^5*, Josep Tabernero^6*, Maria Elena Elez-Fernandez^6*, Jürgen S. Wolf^7*, Florin Sirzen^8*, Andrew Yee^1*, Jason Faris^1*, Martin Kaiser^2*, Heather Landau^3*, Jean-Marie Michot^4*, Luisa Veronese^8*, Martina Makrutzki^8*, Susan Francis Lasserre^8*, Igor Puzanov^9* and Jose Baselga^3*

¹Massachusetts General Hospital, Boston, MA
²The Royal Marsden Hospital, Surrey, United Kingdom
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴Institut Gustave Roussy, Villejuif, France
⁵Centre Leon-Berard, Lyon, France
⁶Vall d´Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain
⁷University Hospital Köln, Köln, Germany
⁸F. Hoffmann-La Roche Ltd., Basel, Switzerland
⁹Vanderbilt University Medical Center, Nashville, TN

Larysa Sanchez, MD¹, Yucai Wang, MD, PhD¹, Laura McBride, RN, BSN, OCN, CCRP^2*, Elizabeth Bilotti, MSN^3*, David H. Vesole, MD⁴, Joshua Richter, MD², Noa Biran, MD⁴, Palka Anand^2*, Kristin Ivanovski^2*, Ann McNeill, ANP^5* and David S Siegel, MD, PhD⁶

¹Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ
²Hackensack University Medical Center, Hackensack, NJ
³Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA
⁴John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
⁵John Theurer Cancer Center, Hackensack, NJ
⁶Hackensack University Medical Center, John Theurer Cancer Center, Hackensack, NJ

Josiah Land, PharmD^1*, Salma Afifi, PharmD, BCOP^1*, Nelly G. Adel, PharmD, BCOP, BCPS^1*, Sean Devlin, PhD^2*, Arshi Arora, MS^3*, Nikoletta Lendvai, MD, PhD^4,5 and Ola Landgren, MD, PhD^4,5

¹Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Department of Medicine, Weill Cornell Medical College, New York, NY